ERD

WAC-mTOR-OC | Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.

01-09-2024

-

31-08-2026

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

INN-TIME | Co-option of host circadian rhythms in cancer

01-03-2024

-

28-02-2029

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

TargetRANK | Targeting RANK receptor as a novel therapeutic strategy in triple negative breast cancer

01-03-2023

-

31-08-2024

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer

01-01-2017

-

31-12-2022

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

ALTER-brain | Metastasis-associated altered molecular patterns in the brain

01-07-2020

-

30-06-2025

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

SHELTERINS | Targeting Shelterin Proteins in Cancer

01-07-2020

-

30-06-2025

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

PDASwITch | Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer

01-09-2020

-

31-08-2022

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

METMEL | Long range-acting drivers of premetastatic niches in melanoma

01-04-2017

-

13-11-2021

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

P70-IMMUNEBREAST | Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications

01-01-2021

-

05-03-2023

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

MAtChinG | Mechanically Activated Channels in Glioma: the role of mechanoreceptor Piezo1 and hnRNP K in cancer as novel oncoregulators

01-09-2021

-

31-08-2023

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma

01-01-2017

-

31-12-2018

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

BREASTCANCERSTEM | The CD44-RANK-AKT Crosstalk in Breast Cancer and Stemness

05-10-2022

-

06-10-2022

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

HD-BRECA | Integrating longitudinal multi-modal profiling of metastatic breast cancer patients for high-definition oncology

01-06-2024

-

31-05-2026

Show more information

Organisation FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Projects overview

Selected filters:

WAC-mTOR-OC | Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.

INN-TIME | Co-option of host circadian rhythms in cancer

TargetRANK | Targeting RANK receptor as a novel therapeutic strategy in triple negative breast cancer

THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer

ALTER-brain | Metastasis-associated altered molecular patterns in the brain

SHELTERINS | Targeting Shelterin Proteins in Cancer

PDASwITch | Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer

METMEL | Long range-acting drivers of premetastatic niches in melanoma

P70-IMMUNEBREAST | Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications

MAtChinG | Mechanically Activated Channels in Glioma: the role of mechanoreceptor Piezo1 and hnRNP K in cancer as novel oncoregulators

DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma

BREASTCANCERSTEM | The CD44-RANK-AKT Crosstalk in Breast Cancer and Stemness

HD-BRECA | Integrating longitudinal multi-modal profiling of metastatic breast cancer patients for high-definition oncology